Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Ionis Pharmaceuticals Inc. logo

Ionis Pharmaceuticals Inc.

Sector: Healthcare   

Industry: Biotechnology

41.83
 
USD
  
1.02
  
(2.50%)
Optionable: Yes  Market Cap: 5,932 M  90-day average vol: 1,049,779

Previous close: 40.81  Open: 41.01  Bid: 39.82  Ask: 44.81
52 week range    
35.95   
   54.44
Last updated: Monday 24th June 2024

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)
Financials

IONS Income Statement

Annual
Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22Dec-23
AcquiredInProcessRnD75000.0
AcquiredInProcessRnDIncome56000.0-8 M
Basic EPS from continuing operations-0.33-0.74-0.720.152.09-0.2-1.9-2.56
Basic EPS total-0.33-0.74-0.720.152.092.12-3.18-0.2-1.9-2.56
Basic weighted shares outstanding118 M120 M121 M124 M132 M140 M140 M141 M142 M143 M
Cost of sales0.0416 M-4 M-12 M11 M14 M9 M
Diluted EPS total0.25-0.59-0.720.152.072.08-3.18-0.2-1.9-2.56
Diluted normalized net income/share0.25-0.59-0.720.152.07-0.2-1.9-2.56
Diluted weighted shares outstanding123 M120 M121 M126 M134 M143 M140 M141 M142 M143 M
Earnings from equity interest20 M
EarningsFromEquityInterestNetOfTax20 M
GainOnSaleOfPPE-8 M150 M-161000.0
GainOnSaleOfSecurity21 M20 M192000.017 M20 M18 M87 M
GeneralAndAdministrativeExpense20 M37 M49 M108 M245 M-4 M-4 M186 M150 M233 M
Gross operating profit203 M302 M347 M514 M183 M653 M182 M800 M573 M779 M
ImpairmentOfCapitalAssets-1 M-2 M-2 M-800000.0-800000.0-2 M-2 M3 M
Income before tax-66 M-90 M-84 M-17 M-76 M339 M-135 M-29 M-258 M-334 M
Income taxes-15 M372000.03 M-6 M-291 M44 M345 M-551000.012 M32 M
InterestExpenseNonOperating22 M37 M39 M45 M45 M49 M10 M9 M8 M13 M
InterestIncomeOperating75000.0
MinorityInterests11 M59 M-9 M35 M
MiscOtherSpecialCharges-8 M-4 M-4 M-182000.0-23 M-62000.0-10 M-7 M14 M
Net income from total operations-51 M-91 M-87 M346000.0274 M294 M-444 M-29 M-270 M-366 M
NetIncomeCommonStockholders-51 M-91 M-87 M346000.0274 M294 M-444 M-29 M-270 M-366 M
NetIncomeContinuousOperations-51 M-91 M-87 M346000.0274 M294 M-444 M-29 M-270 M-366 M
NetNonOperatingInterestIncomeExpense-20 M-32 M-33 M-37 M-15 M3 M21 M-9 M-8 M-13 M
Normalized income-30 M-353 M-264 M
Operating income-59 M-58 M-46 M31 M-61 M366 M-172 M-30 M-410 M-354 M
Operating income before depreciation (EBITDA)-20 M-28 M3 M79 M15 M435 M-93 M22 M-215 M-321 M
OperatingExpense262 M359 M393 M483 M245 M287 M354 M186 M150 M233 M
Other income net-12 M-20 M4 M11 M182000.022 M-16 M-10 M-160 M-101 M
OtherGandA20 M37 M49 M108 M245 M-4 M-4 M186 M150 M233 M
OtherImpairmentOfCapitalAssets0.0
OtherOperatingExpenses242 M322 M344 M375 M-3 M-2 M-2 M-1 M-150 M-2 M
RentAndLandingFees0.0
Research & development expense-239 M-319 M-340 M-372 M-412 M-461 M-531 M638 M
ResearchExpense-239 M-319 M-340 M-372 M-412 M638 M
Revenue per share-10 M-23 M-25 M-32 M-35 M-39 M-3 M5 M5 M6 M
SalariesAndWages-147 M-230 M
Selling Gen & administrative expense20 M37 M49 M108 M245 M287 M354 M186 M150 M233 M
SellingAndMarketingExpense287 M354 M
SellingExpense287 M354 M
Special income/charges1 M2 M2 M800000.0800000.02 M2 M-3 M
Total Income available for interest expense (EBIT)-44 M-54 M-45 M28 M-31 M388 M-125 M-20 M-250 M-321 M
Total common shares outstanding119 M121 M124 M125 M138 M139 M141 M142 M143 M146 M
Total net income-51 M-91 M-87 M346000.0274 M294 M-444 M-29 M-270 M-366 M
Total ordinary shares146 M146 M146 M146 M146 M146 M146 M146 M146 M146 M
Total revenues203 M302 M347 M514 M600 M1,123 M729 M810 M587 M788 M
TotalExpenses262 M359 M393 M483 M661 M282 M342 M197 M164 M242 M
TotalRevenue203 M302 M347 M514 M600 M1,123 M729 M810 M587 M788 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University